ESC Study Group of Sports Cardiology Position Paper on adverse cardiovascular effects of doping in athletes
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The use of doping substances and methods is extensive not only among elite athletes, but also among amateur and recreational athletes. Many types of drugs are used by athletes to enhance performance, to reduce anxiety, to increase muscle mass, to reduce weight or to mask the use of other drugs during testing. However, the abuse of doping substances and methods has been associated with the occurrence of numerous health side-effects. The adverse effects depend on the type of the consumed drug, as well as the amount and duration of intake and the sensitivity of the body, since there is a large inter-individual variability in responses to a drug. Usually the doses used in sports are much higher than those used for therapeutic purposes and the use of several drugs in combination is frequent, leading to higher risk of side-effects. Among biomedical side-effects of doping, the cardiovascular ones are the most deleterious. Myocardial infarction, hyperlipidemia, hypertension, thrombosis, arrythmogenesis, heart failure and sudden cardiac death have been noted following drug abuse. This paper reviews the literature on the adverse cardiovascular effects after abuse of prohibited substances and methods in athletes, aiming to inform physicians, trainers and athletes and to discourage individuals from using drugs during sports.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Haller, C. A., & Benowitz, N. L. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012213432502 · Cited by 956
Caffeine and Exercise: Metabolism, Endurance and Performance
Graham, T. E. (2001) · Sports Medicine · doi:10.2165/00007256-200131110-00002 · Cited by 819
Cited by
Role of β-Adrenoceptor Signaling in Skeletal Muscle: Implications for Muscle Wasting and Disease
Lynch, G. S., & Ryall, J. G. (2008) · Physiological Reviews · doi:10.1152/physrev.00028.2007 · Cited by 410
Exercise and the heart: the good, the bad, and the ugly
Sharma, S., Merghani, A., & Mont, L. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv090 · Cited by 398
“Although deaths in competitive athlete afford considerable media attention, over 90% of all exercise-related SCDs occur in recreational athletes.37,38 Cardiovascular screening to identify athletes predisposed to exercise-related SCD is controversial given the low event rates but data from a large prospective Italian s…”
BackgroundInfluentialPelliccia, A., Caselli, S., Sharma, S., Basso, C., Bax, J. J., Corrado, D., D’Andrea, A., D’Ascenzi, F., Di Paolo, F. M., Edvardsen, T., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx532 · Cited by 368
Zorzi, A., Perazzolo Marra, M., Rigato, I., De Lazzari, M., Susana, A., Niero, A., Pilichou, K., Migliore, F., Rizzo, S., Giorgi, B., et al. (2016) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.116.004229 · Cited by 326
“Late potentials at SAECG 6/15 (40) 1/20 (5) .”
Comprehensive review of cardiovascular toxicity of drugs and related agents
Mladěnka, P., Applová, L., Patočka, J., Costa, V. M., Remiao, F., Pourová, J., Mladěnka, A., Karlíčková, J., Jahodář, L., Vopršalová, M., et al. (2018) · Medicinal Research Reviews · doi:10.1002/med.21476 · Cited by 310
Metadata
- Authors
- Deligiannis, A., Björnstad, H., Carre, F., Heidbüchel, H., Kouidi, E., Panhuyzen-Goedkoop, N. M., Pigozzi, F., Schänzer, W., Vanhees, L., & on behalf of the ESC Study Group of Sports Cardiology
- Venue
- European Journal of Cardiovascular Prevention & Rehabilitation
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-10
- Volume
- 13
- Issue
- 5
- Pages
- 687-694
- ISSN
- 1741-8267 (ISSN-L)
- OpenAlex
- W2158034785
- Cited by
- 117
- References
- 2
- FWCI
- 18.44
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: ESC Study Group of Sports Cardiology Position Paper on adverse cardiovascular effects of doping in athletes. https://app.cochat.ai/papers/10.1097/01.hjr.0000224482.95597.7a
- The paper
- Deligiannis, A., Björnstad, H., Carre, F., Heidbüchel, H., Kouidi, E., Panhuyzen-Goedkoop, N. M., Pigozzi, F., Schänzer, W., Vanhees, L., & on behalf of the ESC Study Group of Sports Cardiology. (2006). ESC Study Group of Sports Cardiology Position Paper on adverse cardiovascular effects of doping in athletes. European Journal of Cardiovascular Prevention & Rehabilitation. https://doi.org/10.1097/01.hjr.0000224482.95597.7a
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.